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Cellular adherens junctions are formed by cadherins
linked to proteins of the catenin family. In endothe-
lial cells, not only vascular endothelial cadherin but
also platelet endothelial cell adhesion molecule-1
localizes into junctions and associates with b-catenin.
To explore a putative cooperation of platelet endo-
thelial cell adhesion molecule-1 and vascular endo-
thelial cadherin, we analyzed transfectants expressing
either platelet endothelial cell adhesion (CD31 cells)
or vascular endothelial cadherin (CD144 cells) or
both molecules (CD31/CD144 cells), and, for com-
parison, human umbilical vein endothelial cells.
Basic ®broblast growth factor completely dissociated
vascular endothelial cadherin/b-catenin complexes
and robustly moved b-catenin into the nucleus in
CD144 cells, whereas in CD31/CD144 cells as well as
in human umbilical vein endothelial cells, ®broblast
growth factor only partially dissociated the junctional
complex followed by a signi®cantly reduced nuclear
translocation of b-catenin. In contrast, in CD31 cells,
the subcellular distribution of b-catenin remained
unaffected by ®broblast growth factor. As a func-
tional consequence, ®broblast growth factor induced
a complete collapse of the F-actin network in CD144
cells, a limited rearrangement of F-actin ®bers in
CD31/CD144 cells and no F-actin rearrangement in
CD31 cells. We also analyzed the effect of ®broblast
growth factor-induced rearrangement of junctions
on junction permeability for leukocytes: in line with
our observation that vascular endothelial cadherin
was required for cells to respond to ®broblast growth
factor, only in CD31/CD144 cells, but not in CD31
cells, leukocyte transmigration was signi®cantly
enhanced by ®broblast growth factor. In conclusion
platelet endothelial cell adhesion molecule-1 co-
operates with vascular endothelial cadherin in a
mutual fashion; platelet endothelial cell adhesion
molecule-1 reduces and temporarily limits ®broblast
growth factor-induced dissociation of vascular
endothelial cadherin/b-catenin complexes, but
requires vascular endothelial cadherin to control leu-
kocyte transmigration in dependence of ®broblast
growth factor. Key words: actin/b -catenin/CD31/
CD144/transmigration. J Invest Dermatol 116:110±117,
2001
S
everal in vivo and in vitro studies have elaborated a role for
platelet endothelial cell adhesion molecule-1 (PECAM-1,
also called CD31) in vessel formation and leukocyte
migration through vascular barriers (Albelda et al, 1990;
Tanaka et al, 1992; Berman and Muller, 1995; DeLisser
et al, 1997; Matsumura et al, 1997; Pellegatta et al, 1998). PECAM-
1 is a 130 kDa transmembrane molecule of the immunoglobulin
gene superfamily constitutively expressed on all endothelial cells.
The extracellular domain of PECAM-1 contains six immunoglo-
bulin-like homology domains, which support cell±cell adhesion by
interacting with homotypic as well as heterotypic ligands (Muller et
al, 1989; Piali et al, 1995; Prager et al, 1996). The cytoplasmic tail of
PECAM-1 contains numerous potential sites for the phosphoryl-
ation of serine, threonine, and tyrosine residues (Newman et al,
1990; Lu et al, 1997). Upon phosphorylation of the tyrosine
residues Y-663 and Y-686, PECAM-1 associates with protein
tyrosine phosphatases SHP-1 and SHP-2 (Jackson et al, 1997; Hua
et al, 1998; Newton-Nash and Newman, 1999) as well as the
phospholipase C-g 1 and the inositol 5¢-phosphatase SHIP
(Pumphrey et al, 1999); however, it was only partially possible to
match the downstream signal transduction of PECAM-1 with
biological functions of PECAM-1 (Poggi et al, 1996; Jackson et al,
1997; Pellagatta et al, 1998; Newton-Nash and Newman 1999).
Notwithstanding the considerable body of evidence that PECAM-
1 is a potent signaling molecule and important for vessel formation
and leukocyte migration, a PECAM-1-de®cient mouse had a
surprisingly mild phenotype; the vascular development was normal
and leukocyte transmigration was only mildly affected (Duncan et
al, 1999), indicating that PECAM-1 exerts its function in
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conjunction with other molecules, whichÐat least partiallyÐcan
compensate for the absence of PECAM-1.
The other constitutively expressed transmembrane adhesion
molecule implicated in the regulation of endothelial tube formation
during vasculogenesis and angiogenesis as well as in mechanisms
in¯uencing leukocyte transmigration is vascular endothelial cad-
herin (VE-cadherin, also called cadherin-5 or CD144) (Del
Maschio et al, 1996; Allport et al, 1997; Vittet et al, 1997). In
contrast to the situation seen with PECAM-1, a VE-cadherin
knockout mouse is unable to organize endothelial cells into vessel-
like patterns (Vittet et al, 1997), indicating that VE-cadherin is
irreplaceable for vessel formation. The expression of this 130 kDa
protein is restricted to endothelial adherens junctions. The
extracellular domain mediates homotypic cell contacts between
adjacent endothelial cells (Lampugnani et al, 1992) and the
cytoplasmic tail forms a complex with proteins of the catenin
family and the F-actin-based cytoskeleton. Many lines of evidence
suggest that catenins critically interfere with VE-cadherin function
and vice versa. Cadherin-mediated adhesion progresses from a
weak to a strong state, which depends on cadherin clustering and
subsequent linkage to catenins and the cytoskeleton (Navarro et al,
1995; Adams et al, 1998; Yap et al, 1998; Aono et al, 1999). On the
other hand, cadherin binding to b-catenin reduces the pool of
b-catenin available for nuclear translocation (Fagotto et al, 1996;
Torres et al, 1996; Papkoff, 1997; Orsulic et al, 1999), where
b-catenin interacts with and modulates the activity of a Lef/Tcf
family of transcription factors (Behrens et al, 1996; Shtutman et al,
1999; Mann et al, 1999). The crucial importance of the interaction
of VE-cadherin with b-catenin is substantiated by the ®nding that
not only the VE-cadherin knockout mouse, but also mice
expressing a cytoplasmic truncation mutant of VE-cadherin, which
fails to interact with b-catenin, have impaired vascular develop-
ment and maturation (Carmeliet et al, 1999).
As outlined above, signaling properties of PECAM-1 and VE-
cadherin are largely independent and yet there are no data available
that describe an interference of PECAM-1 with VE-cadherin-
dependent functions; however, based on light and electron
microscopic studies showing that PECAM-1 colocalizes with
VE-cadherin into junctional regions (Leach et al, 1993; Ayalon et al,
1994) and based on immunoprecipitation studies showing that
PECAM-1 coprecipitates b-catenin (Matsumura et al, 1997; Ilan et
al, 1999), we wished to explore if PECAM-1 operates as a regulator
of adherens junction function.
MATERIALS AND METHODS
Cells and reagents ECV304 cells (ATCC, Rockville, MD) were
transfected with either PECAM-1 (CD31 cells) or with VE-cadherin
(CD144 cells) or with cDNA for both proteins (CD31±CD144 cells) and
subcultured as described previously (Halama et al, 1999). For each of the
three transfectants, a set of at least four different single cell-derived clones
was used for all following experiments. HUVEC were isolated and
subcultured as described (Matsumura et al, 1997).
Preparation of full cell extracts for immunoprecipitation and
western blotting Cells (53107) were lysed in 1 ml lysis buffer (10 mM
Tris±HCl, pH 7.5, 150 mM NaCl, 2 mM CaCl, 1 mM
phenylmethylsulfonyl ¯uoride, 10 mg aprotinin per ml, 15 mg leupeptin
per ml, 1% nonidet P-40 and 1% Triton-X100), homogenized with a
motor-driven Te¯on-type Elvehjem-Potter (Kontes, Vineland, NJ),
incubated on ice for 1 h and centrifuged at 10,0003g for 30 min at 4°C.
The supernatants were used for immunoprecipitation and subsequent
immunoblotting as described (Matsumura et al, 1997). The monoclonal
antibodies used were: anti-VE-cadherin (TEA1/31, Immunotech,
Marseilles, France), anti-VE-cadherin±biotin (polyclonal rabbit antibody,
BendermedSystems, Vienna Austria), anti-PECAM-1 (7E4) (Matsumura et
al, 1997), anti-PECAM-1-biotin (158-2B3, Ancell Europe, LaÈufelingen,
CH), anti-b-catenin (clone 14), anti-plakoglobin (clone 15, both
Transduction Laboratories, Lexington, KY), and isotype controls. Second
step reagents used were a horseradish peroxidase-conjugated anti-mouse
antibody (BioRad, Hercules, CA) or horseradish peroxidase-conjugated
streptavidin (Stressgen Biotechnologies, Victoria, Canada). Bound
antibodies were visualized by chemiluminescence and recorded on ®lm.
Relative band densities were quanti®ed by the Electrophoresis
Documentation and Analysis System from Kodak (Rochester, NY).
Preparation of cytosolic and nuclear extracts for western
blotting Cells (107) were incubated in 10 mM HEPES, pH 7.9, 1.5
mM MgCl2, 10 mM KCl and 0.5% nonidet P-40 on ice followed by
centrifugation at 8003g for 5 min at 4°C. The supernatants were left on ice
for 45 min, centrifuged at 10,0003g for 5 min at 4°C and supernatants
were collected (detergent soluble fraction largely containing cytosolic
material). For the preparation of nuclear extracts, the pellets derived after
the 8003g centrifugation step (see above) containing the intact nuclei as
well as F-actin were washed in 10 mM HEPES, pH 7.9, 1.5 mM MgCl2,
10 mM KCl. The material was then resuspended in a hypertonic salt buffer
containing 20 mM HEPES, pH 7.9, 10% glycerol, 420 mM NaCl, 1.5 mM
ethylenediamine tetraacetic acid and incubated for 45 min on ice. After
centrifugation at 10,0003g for 5 min at 4°C, which pellets most of actin-
bound proteins and membrane components, the supernatants containing
the nuclear extracts were collected (Dignam, 1990; Lechleitner et al, 1998)
and protein concentrations adjusted to 0.5 mg per ml.
Immuno¯uorescence studies Cells were grown to con¯uence on
chamber slides (Nunc, Roskilde, DK), ®xed in 4% paraformaldehyde/
phosphate-buffered saline (PBS) for 15 min at 4°C and cell membranes
were permeabilized with 0.5% Triton X-100/PBS for 2 min. The F-actin-
based cytoskeleton was visualized by ¯uorescein isothiocyanate-conjugated
Phalloidin (Sigma) as described (Matsumura et al, 1997). Nuclei were
stained with propidium iodide. b-catenin was visualized with anti-
b-catenin (clone 14) followed by ¯uorescein isothiocyanate-labeled goat
anti-mouse antibodies (Sigma). Images were taken by confocal laser scan
microscopy (Axiovert100, Zeiss, Germany).
Transmigration assay Transmigration assays were performed by using
our standardized, computer-assisted in vitro assay as described (GroÈger et al,
1999) with some modi®cations. Brie¯y, transfectants were loaded with
CellTracker OrangeÔ (Molecular Probes, Eugene, OR) and seeded on top
of collagen gels, which contained MCP-1, macrophage in¯ammatory
protein-1a, RANTES (8 ng per ml each; Endogen, Woburn, MA), and
IP-10 (10 ng per ml, R&D, Minneapolis, MN). After con¯uence, cells
were kept in culture for an additional 24 h. Then, peripheral blood
mononuclear cells were prepared by density gradient centrifugation and
loaded with CellTracker GreenÔ (Molecular Probes). Cells (106 per well)
were seeded on top of the transfectants in the presence of 6 ml per ml anti-
basic FGF (polyclonal rabbit antibody, Strathmann, Hanover, Germany) or
6 ml per ml rabbit serum (control) in RPMI (Life Technology). Cells were
allowed to adhere and to transmigrate for 20 h. Adherent and transmigrated
cells were imaged by confocal laser scan microscopy and analyzed by an
automated computer program as described (GroÈger et al, 1999).
RESULTS
The association of PECAM-1 with b-catenin requires VE-
cadherin expression We have selected the bladder-carcinoma-
derived cell line ECV304 for transfection, because they lack
expression of epithelial or endothelial cadherins or of PECAM-1,
but express a-, b-, and g-catenin (plakoglobin) (Halama et al,
1999). In CD31±CD144 cells, VE-cadherin as well as PECAM-1
coprecipitated b-catenin (Fig 1). Also the reverse experiment,
precipitation with b-catenin, coprecipitated PECAM-1 as well as
VE-cadherin in these cells (data not shown). As VE-cadherin and
PECAM-1 did not coprecipitate (Fig 1), they most likely associate
with separate b-catenin molecules. g-catenin coprecipitated with
VE-cadherin only but not with PECAM-1 (Fig 1). Thus, with
regard to the composition of junctional protein complexes, our
CD31±CD144 cells resembled human umbilical vein endothelial
cells (HUVEC), where b-catenin associates with VE-cadherin as
well as with PECAM-1 (Matsumura et al, 1997; Ilan et al, 1999) and
g-catenin with VE-cadherin only (Kowalczyk et al, 1998). Also in
CD144 cells, VE-cadherin coprecipitated b-catenin as well as
g-catenin. By contrast, in CD31 cells, PECAM-1 was unable to
coprecipitate any catenin (Halama et al, 1999).
FGF-induced dissociation and subsequent reformation of
junctional complexes In CD31±CD144 cells, basic FGF (20 ng
per ml plus 5 U per ml heparin) induced a partial dissociation of
VE-cadherin/b-catenin complexes, which maximized between 8
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and 24 h following FGF stimulation (minus 60% from baseline, Fig
2). Within 4 h following FGF withdrawal, VE-cadherin/
b-cadherin complexes had completely reassembled to the extent
seen at baseline. Most interestingly, PECAM-1/b-catenin
complexes remained stable even in the presence of FGF (Fig 2).
HUVEC, analyzed for comparison, had similar kinetics of VE-
cadherin/b-cadherin complex dissociation in response to FGF (Fig
2). In striking contrast, in CD144 cells, FGF completely disrupted
VE-cadherin/b-catenin complexes and reassembly of complexes
was not completed before 48 h after FGF withdrawal (Fig 2). In
none of the cell types there was a change in the total amount of
VE-cadherin (Fig 2) and/or of PECAM-1 (not shown) during the
time course of the experiment.
Laser scan images supported the results obtained by immuno-
precipitation (Fig 3). b-catenin localized to junctional regions only
in CD31/CD144 cells and in CD144 cells but not in CD31 cells.
Upon FGF stimulation, junctional localization of b-catenin was
almost completely lost in CD144 cells, whereas in CD31/CD144
cells a considerable amount of b-catenin remained in junctional
regions. In CD31 cells FGF did not alter the subcellular distribution
of b-catenin (Fig 3).
FGF-induced nuclear translocation of b-catenin In CD31±
CD144 cells, FGF, 20 ng per ml, induced a rise in cytosolic as well
as nuclear b-catenin levels within 2 h of stimulation (mean 2-fold
above baseline), which returned to baseline within 18 h (Fig 4). In
HUVEC, kinetics of FGF-induced nuclear translocation of
b-catenin were comparable with CD31±CD144 cells (Fig 4D).
In striking contrast to CD31±CD144 cells and HUVEC, in
CD144 cells, cytosolic as well as nuclear b-catenin showed a steep
and prolonged increase in response to FGF (4-fold above baseline,
Fig 4) and remained elevated for more than 18 h. On the other
hand, in CD31 cells, b-catenin levels within the cytosolic as well as
nuclear compartments remained unchanged, whether FGF was
present or not (Fig 4).
Coomassie Blue stainings of sodium dodecyl sulfate gels were run
in parallel to con®rm equal loading of lanes (example shown in Fig
4C). Moreover, controls employing full cell extracts of each cell
type and each time point, containing the cytosolic, the nuclear as
well as the F-actin-linked compartments were run in parallel.
During the time course of all these experiments, the total amount
of b-catenin protein (example shown in Fig 4C) remained
unchanged, whether FGF was present of not. Moreover, FGF
did not change the amount of b-catenin mRNA during the time
course of the experiment (analyzed by semiquantitative reverse
transcription±polymerase chain reaction, data not shown), which
largely excludes b-catenin degradation or de novo synthesis. In all
experiments, also g-catenin was analyzed and in none of the cell
types, FGF was able signi®cantly to alter amounts of nuclear
g-catenin (data not shown).
Laser scan images supported the results obtained by analyzing cell
extracts (Fig 3). Following FGF stimulation, a translocation of b-
catenin from the membrane into the cytosol and into the nucleus
was only seen in CD31/CD144 cells and CD144 cells, but not in
CD31 cells (Fig 3).
FGF-induced polarization of F-actin CD31±CD144 cells as
well as CD144 cells produced a cobblestone-like growth pattern in
cell culture identical to that seen with HUVEC (Matsumura et al,
1997; Halama et al, 1999). F-actin ®bers were arranged in parallel
bundles reaching from one cell border to the other and cells
maintained a strict monolayer (Fig 5). Following FGF stimulation,
cells released their cell contacts and F-actin condensed in small
protrusions at sites that had lost lateral cell±cell contact (Fig 5;
arrows). Most importantly, in CD144 cells almost all the F-actin
condensed into these protrusions (Fig 5 arrows; mean numbers of
protrusions/cell were 4.560.8; results from four independent
experiments), whereas in CD31±CD144 cells, considerable
amounts of F-actin ®bers remained stretched even in the
presence of FGF and numbers of protrusions per cell were
signi®cantly reduced compared with CD144 cells (mean 1.460.2,
p<0.001). It should be noted that the FGF-induced polarization of
F-actin was completely blocked by cycloheximide (2 mg per ml;
data not shown), indicating that FGF-induced polarization of
F-actin depended on de novo potein synthesis.
Following FGF withdrawal, in CD31±CD144 cells, a realign-
ment of F-actin ®bers was seen within 24 h. In contrast, at this time
point F-actin was still diffusely distributed throughout the
cytoplasm in CD144 cells and a realignment of F-actin ®bers was
not detectable until 48 h following FGF withdrawal (Fig 5).
CD31 cells were considerably smaller than CD144 or CD31±
CD144 cells, grew in polylayers and b-catenin was not targeted to
junctional areas (Halama et al, 1999). Most importantly, F-actin was
diffusely distributed throughout the cytosol at baseline (Fig 5) and
FGF was unable to induce a polarization of F-actin as FGF did not
induce a release of cell±cell contacts (Fig 5). It should be noted that
Ilan et al (1999) transfected PECAM-1 into SW480 cells, which
resulted in a localization of b-catenin to the cell membrane even in
the absence of VE-cadherin. This discrepancy with our CD31 cells
might be due to the fact that SW480 cells express a mutant
adenomatosis polyposis coli protein, which causes constitutively
elevated levels of free cytosolic b-catenin (Simcha et al, 1998).
Transmigration is most ef®cient in PECAM-1/VE-cadherin
double transfectants and is inhibited by anti-FGF
antibodies To test the functional consequences of PECAM-1
on the permeability of VE-cadherin-containing junctions for
leukocyte transmigration, a semiautomated migration assay
(GroÈger et al, 1999) was employed with some modi®cations. To
ensure vigorous leukocyte transmigration across ECV304 cells, a
chemotactic gradient was created by incorporating a chemokine
cocktail in the gel (see Materials and Methods). Under these
conditions, CD144 cells were rather impermeable for leukocytes
with the adhesion/migration ratio being approximately 20 : 1 (Fig
6). CD31 cells were more permeable for leukocyte transmigration
(Fig 6), the adhesion/migration ratio being in the range of 10 : 1
(p<0.05). Given the large numbers of reports detailing the
Figure 1. Composition of adherens junctions in transfectants. Full
cell extracts as described in the Materials and Methods section were
immunoprecipitates with anti-VE-cadherin or anti-PECAM-1 antibodies
and detection antibodies used in the subsequent immunoblot are indicated
at the bottom of the ®gure. Of note, in the absence of VE-cadherin,
PECAM-1 is unable to coprecipitate b-catenin (lower right panel).
112 HALAMA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
importance of PECAM-1 in leukocyte transmigration (Berman and
Muller, 1995; Piali et al, 1995; Poggi et al, 1996; Prager et al, 1996;
Pellegatta et al, 1998), we attributed the leukocyte transmigration
seen across CD31 cells mainly to PECAM-1 interactions with
ligands expressed on the leukocytes rather than being dependent on
reduced junction adhesiveness.
Most interestingly, CD31±CD144 cells were highly permeable
for leukocytes, the adhesion/migration ratio being 2.5 : 1 (Fig 6;
p<0.05 as compared with CD31 cells and CD144 cells), which was
well within the range of the transmigration ef®cacy when
unstimulated HUVEC were used in this modi®ed migration assay
(Fig 6). In view of the experiments described in Figs 2, 3, and 5
showing that VE-cadherin/PECAM-1 coexpression enhances
junction stability, this enhanced transmigration seen across
CD31±CD144 cells was unexpected. As monocytes are a rich
source of FGF (Arras et al, 1998) and as the adhesive strength of
PECAM-1/VE-cadherin-containing junctional regions is regulated
by FGF, we tested the effect of neutralizing antibodies against FGF
in this system. Indeed, anti-FGF blocked leukocyte transmigration
across CD31±CD144 cells by approximately 75% and across
HUVEC by 50% (Fig 6; p<0.05 compared with controls).
In contrast to the situation seen in CD31±CD144 cells and
HUVEC, in CD31 cells, leukocyte transmigration was not affected
by anti-FGF. In CD144 cells, leukocyte transmigration was
negligible whether anti-FGF was present or not (Fig 6).
DISCUSSION
PECAM-1 and VE-cadherin participate in several interrelated
endothelial functions such as vessel formation and leukocyte
transmigration, but it is unknown whether VE-cadherin interferes
with PECAM-1-dependent functions and vice versa. It is well
documented that cadherin/b-catenin complexes control cell
adhesion and transfer signals to and between cells. The interactions
between cadherins and catenins are dynamic and regulated by FGF,
hepatocyte growth factor, epidermal growth factor, or thrombin
(Hoschuetzky et al, 1994; Rabiet et al, 1996; Hazan and Norton,
1998; Hiscox, 1999).
Our initial experiments showed that PECAM-1 reduced and
temporarily limited the FGF-induced dissociation of VE-cadherin/
catenin complexes. This stabilizing effect of PECAM-1 is most
likely mediated indirectly, because PECAM-1 and VE-cadherin do
not physically interact. As the cytoplasmic tails of PECAM-1 and
VE-cadherin have no homology, they likely use distinct region on
b-catenin for binding. Signals regulating the stability of the VE-
cadherin/catenin complexes are only partially understood. The
association of protein-tyrosine phosphatases such as PTPmu, PTP-
1B, or LAR-PTP with the VE-cadherin/b-catenin complex have
been shown to increase the cohesivity of the complex (Kypta et al,
1996; Balsamo et al, 1998; Brady-Kalnay et al, 1998; Muller et al,
1999). As also PECAM-1 can associate with protein-tyrosine
phosphatases via its src homology 2 domain binding motif (Jackson
et al, 1997; Hua et al, 1998; Newton-Nash and Newman, 1999),
this may interfere with the stability of the cadherin/catenin
complexes, but the design of our experiments did not address this
question.
Following FGF stimulation, the nuclear translocation of
b-catenin is 2±3-fold less in CD31±CD144 cells as compared with
CD144 cells. The simplest explanation for this effect is based on our
observation that PECAM-1 stabilizes VE-cadherin/b-catenin
complexes, which results in a quantitative reduction of b-catenin
available for nuclear translocation. Although the source of nuclear
Figure 2. FGF-induced dissociation and sub-
sequent reformation of junctional complexes.
(A) Cells were pulsed with 20 ng per ml FGF, 5
U per ml heparin for 24 h followed by wash out
and culture for another 24 h. At indicated time
points, cells were lysed in lysis buffer containing
1% nonidet P-40, 1% Triton-X100 to generate
full cell extracts as described in the Materials and
Methods section. Immunoprecipitation was per-
formed by using the indicated monoclonal anti-
bodies and the immunoprecipitated material was
subjected to electrophoresis and immunoblotting
by using the indicated monoclonal antibodies. (B)
Employing three different clones from CD31±
CD144 cells or CD144 cells, the relative amount
of coprecipitated b-catenin was determined in
three independent experiments. (C ) Employing
HUVEC, the relative amount of coprecipitated
b-catenin was determined in three independent
experiments.
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b-catenin is still under debate, there are many lines of evidence that
the binding of b-catenin to junctional regions antagonizes the
signaling properties of b-catenin (Fagotto et al, 1996; Torres et al,
1996; Papkoff, 1997; Orsulic et al, 1999). We show that FGF did
not alter the total cellular amount of b-catenin, but reduced the
junctional pools and subsequently increased the cytosolic and the
nuclear pools of b-catenin. Moreover, in CD31 cells, where
PECAM-1 was unable to bind and localize b-catenin to the cell
membrane (Halama et al, 1999), FGF was unable to alter the
subcellular distribution of b-catenin (Figs 3 and 4), which supports
the view that FGF translocated junctional catenin into the nucleus.
The situation is complicated by the fact that the steady-state levels
of cytosolic b-catenin levels are not only controlled by transmem-
brane proteins, but also by several interacting proteins within the
cytosol, including, e.g., axin, adenomatosis polyposis coli protein,
and the protein kinase GSK-3b (Papkoff et al, 1996; Hart et al,
1998; Ikeda et al, 1998; Willert et al, 1999); however, their role in
regulating b-catenin activity and stability has been largely
investigated in response to Wnt but not to FGF signals. Wnt-1-
induced nuclear translocation of b-catenin has recently been found
to also function in human endothelial cells (Wright et al, 1999), but
it remains yet unresolved, whether the FGF-induced nuclear
translocation of b-catenin, which in our system requires junctional
b-catenin, depends on or bypasses cytosolic regulatory proteins of
b-catenin activity. An adenomatosis polyposis coli protein-
independent regulation of b-catenin activity has been described
in colon carcinoma cell lines following phorbol myristate acetate
stimulation (Baulida et al, 1999).
Figure 3. Laser scan images of b-catenin distribution in unstimu-
lated and FGF-stimulated cells. In the absence of FGF (three panels on
the left side), CD31/CD144 cells>CD144 cells, but not CD31 cells show
signi®cant anti-b-catenin staining of junctional regions (arrows). Cytosolic
b-catenin is only seen in CD31 cells. Following 12 h stimulation with 20
ng per ml FGF, 5 U per ml heparin (three panels on the right side),
junctional b-catenin staining is reduced in CD31/CD144 cells and almost
completely lost in CD144 cells. Both cell types show increased amounts of
cytosolic as well as nuclear b-catenin as compared with the corresponding
unstimulated cells. In CD31 cells the distribution of b-catenin does not
change following FGF stimulation; scale bar, 10 mm.
Figure 4. FGF-induced nuclear translocation of b-catenin. (A) Cells
were pulsed for indicated times with 20 ng per ml FGF, 5 U per ml heparin
and lysed in buffer containing 0.5% nonidet P-40. Supernatants containing
the detergent soluble (cytosolic) fraction were collected and immuno-
blotted (left panel). Pellets containing the nuclei were lysed in 420 mM
hypertonic salt buffer as described in the Materials and Methods section and
the supernatants containing the nuclear extracts (Dignam, 1990) were
collected and immunoblotted (right panel). (B) The relative amount of b-
catenin was determined in three independent experiments employing three
different clones for each transfectant. (C ) Representative example of an
anti-b-catenin immunoblot using a full cell extract and of a Coomassie Blue
staining of a nuclear extract from CD144 cells following FGF stimulation.
(D) Representative example of nuclear extracts derived from HUVEC at
indicated times following FGF stimulation. The relative amounts of
cytosolic and nuclear b-catenin were determined in two independent
experiments; mean values are given.
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We (Halama et al 1999) and others (Breviario et al, 1995; Caveda
et al, 1996) have previously shown that transfection of VE-cadherin
alone, even in the absence of PECAM-1, is suf®cient to mediate
monolayer formation, cell contact-dependent growth arrest and
tube formation irrespective of the cell type used for transfection.
Under unstimulated conditions, such transfected cells mimic
growth behavior of real endothelial cells (Matsumura et al, 1997),
indicating that this is independent from PECAM-1. The situation is
different following FGF stimulation. Whereas CD144 cells almost
completely lost their cell±cell contacts and most of the actin
condensed at the protruding edges of the cell, in CD31±CD144
cells the FGF-induced loss of cell contact and the collapse of F-
actin ®bers was signi®cantly reduced and comparable with that seen
in HUVEC. Again, this ®nding is in agreement with our initial
Figure 5. FGF-induced polarization of F-
actin. Cells were grown to con¯uence on tissue
culture plastic, pulsed with 20 ng per ml FGF, 5
U per ml heparin for 24 h followed by FGF with-
drawal, ®xed and stained with phalloidin ¯uores-
cein isothiocyanate to visualize the F-actin-based
cytoskeleton and with propidium iodide to
visualize the nuclei. Representative example of six
independent experiments shown. Arrows point to
condensed actin at protruding edges of the cell
(mean number of actin condensates/cell in CD31±
CD144 cells and CD144 cells were 4.560.8 and
1.460.2, respectively, p<0.001). Note that
realignment of F-actin ®bers into parallel bundles
is seen 24 h following FGF withdrawal in CD31±
CD144 cells, whereas at this time point F-actin
was diffusely distributed throughout the cytoplasm
in CD144 cells. Scale bar, 10 mm.
Figure 6. Transmigration is most ef®cient in
PECAM-1/VE-cadherin double transfectants.
Adhesion and migration of peripheral mono-
nuclear cells across monolayers of transfectants or
of HUVEC as indicated at the bottom of the
graph. Culture medium contained 6 ml per ml
rabbit serum (controls) or 6 ml per ml polyclonal
rabbit anti-FGF antibodies (anti-FGF). Quanti®c-
ation was performed by a computerized migration
assay (GroÈger et al, 1999); mean6SEM of six
independent experiments shown.
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observation that VE-cadherin/b-catenin complexes were only
partially dissociated by FGF in CD31±CD144 cells, thereby
allowing a limited linkage of F-actin to the junction. In contrast,
in CD144 cells, VE-cadherin/b-catenin complexes were comple-
tely disrupted by FGF, resulting in the total collapse of F-actin
®bers. It should be noted that mock-transfected cells (data not
shown), just like CD31 cells, were unable to respond to FGF
stimulation.
To characterize further the functional consequences of FGF-
induced rearrangement of junctions, we performed leukocyte
transmigration studies. With regard to CD31 cells, it is thoroughly
documented that PECAM-1 molecules ``track'' leukocytes through
junctions (Berman and Muller, 1995; Piali et al, 1995; Poggi et al,
1996; Prager et al, 1996; Pellegatta et al, 1998). Thus, CD31 cells
allowed a certain amount of leukocyte transmigration, but this was
not regulated by FGF, inasmuch as FGF was unable to alter the
distribution of b-catenin or F-actin ®ber rearrangement. CD144
cells did not support leukocyte transmigration, whether FGF was
present or not, which we attributed to the fact that ECV-304 cells
lack molecules to ``track'' leukocytes to the junctions. The most
intriguing ®nding is that FGF enhanced leukocyte transmigration in
CD31±CD144 cells and in HUVEC, which correlates with our
observation that FGF opened junctional areas in CD31-CD144
cells and in HUVEC. Our experiments con®rm previous reports
that the dissociation of VE-cadherin/catenin complexes plays an
important part in leukocyte transmigration (Del Maschio et al,
1996; Allport et al, 1997). We extend this knowledge in several
ways: (i) in addition to leukocyte adhesion-induced dissociation of
the adherens junction complex, also a soluble factor, FGF,
dissociates these complexes and supports transmigration;
(ii) PECAM-1-dependent mechanisms of directing the leukocyte
through junctions are regulated by VE-cadherin; and (iii) dis-
sociation of junctions is not suf®cient to allow transmigration as
indicated by the spoiled transmigration in FGF-stimulated CD144
cells. In addition to junction dissociation, transmigration depends
on molecules that ``track'' leukocytes through the junction, which
in our experimental system is PECAM-1; however, it should be
noted that in vivo this function of PECAM-1 appears to be
redundant (Duncan et al, 1999).
In conclusion, we describe a novel functional cooperation
between PECAM-1 and VE-cadherin. The biologic relevance of
results obtained with our transfection system are validated by the
fact that HUVEC behave like the double transfectants in all assays
employed. We demonstrated that VE-cadherin is required for FGF
to induce nuclear translocation of b-catenin, F-actin rearrange-
ment, and cell scattering as well as for FGF to open and close
PECAM-1-dependent pathways of leukocyte transmigration. Most
importantly, we have shown that PECAM-1 operates as a
regulatory component of VE-cadherin-containing adherens junc-
tions. PECAM-1 reduces and temporarily limits FGF-induced
dissociation of VE-cadherin/b-catenin complexes and allows for
their rapid reassembly. This function appears to be particularly
important for ef®cient and fast restoration of the integrity of
endothelial linings following junction dissociation, a condition
given in vivo, e.g., in wound healing or in in¯ammation.
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